Experimental pancreatic cancer pill doubles survival, boosts quality of life
Daraxonrasib reduced the overall risk of death by 60 per cent compared with chemotherapy.
Original Source
Read the full article at Straitstimes →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.